Outpatient Rehabilitation Services Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Glendale Rd, Galax, VA 24333 Phone: 276-236-1675 Fax: 276-236-3399 |
Rebecca Johnson, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 106 W Stuart Dr, Galax, VA 24333 Phone: 276-238-8900 |
Mr. Lynn Nathan Levesque, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 202 Painter St, Galax, VA 24333 Phone: 276-236-5164 Fax: 276-236-9841 |
Lisa Elledge Crotts, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 202 Painter St, Galax, VA 24333 Phone: 276-236-5164 |
Dlp Twin County Regional Healthcare Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Glendale Rd, Galax, VA 24333 Phone: 276-236-1675 Fax: 276-236-3399 |
News Archive
Viacom Inc. and the Henry J. Kaiser Family Foundation today announced the year-three launch of the Emmy and Peabody Award-winning public education initiative KNOW HIV/AIDS, which includes targeted public service announcements (PSAs), HIV-themed programming, and free print and online information resources.
Drinking caffeinated coffee appears to have both beneficial and harmful short-term health effects: increased abnormal heartbeats, increased physical activity and reduced sleep duration, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data showing that herbal medicines have potent activity in test tubes compared to pharmaceuticals commonly-prescribed for the treatment of Bartonella henselae, a bacterium believed to be carried by ticks and the cause of cat scratch fever.
Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body's immune system.
Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.
› Verified 9 days ago